United Kingdom
United Kingdom

The 'go to' European specialist pharma company

Norgine in the UK


Norgine is an affiliate of Norgine B.V, a leading European specialist pharmaceutical company which operates as a single integrated European team to develop transformative products to improve patients’ lives.


Norgine focuses on three core therapy areas: gastroenterology, hepatology cancer and supportive care.


In the UK, Norgine employs around 650 people. Norgine has two sites in the UK, one in Harefield and one in Hengoed.


  • Harefield site: The site houses several of Norgine’s global functions and Norgine’s UK Sales and Marketing operations. The site employs around 300 staff.
  • Hengoed site: In Wales, Norgine makes a considerable contribution to the growth of its life sciences sector. Norgine employs around 330 staff in Wales and is the largest pharmaceutical employer.The Hengoed manufacturing site was opened in 1969. The development center in Hengoed was opened in 2010, next to its manufacturing facilities.





Date of Prep: November 2017

Reporting suspected adverse drug reactions

Adverse events should be reported. Both health professionals and patients can submit information through the Yellow Card website in the UK or the HPRA website in Ireland.

Adverse events should also be reported to Medical Information at Norgine Pharmaceuticals Ltd on 01895 826606.


United Kingdom

The Yellow Card Scheme is run by the Medicines and Healthcare products Regulatory Agency (MHRA) and Commission on Human Medicine (CHM).

The scheme is used to collect information from health professionals and patients on suspected adverse drug reactions (ADRs). The continued success of the Yellow Card Scheme depends on your willingness to report suspected adverse drug reactions. Reporting forms and information can be found at



Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website:; Email: